和铂医药-B(02142)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02142 和铂医药-B

已收盘 11-19 16:08:17

1.200

+0.030

+2.56%

最高1.210	最低1.180	成交量59.50万
今开1.180	昨收1.170	日振幅2.56%
总市值9.23亿	流通市值9.23亿	总股本7.69亿
成交额70.92万	换手率0.08%	流通股本7.69亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02142","market":"HK","secType":"STK","nameCN":"和铂医药-B","latestPrice":1.2,"timestamp":1732003697014,"preClose":1.17,"halted":0,"volume":595000,"delay":0,"floatShares":768876410,"shares":768876410,"eps":0.24176286,"marketStatus":"已收盘","marketStatusCode":5,"change":0.03,"latestTime":"11-19 16:08:17","open":1.18,"high":1.21,"low":1.18,"amount":709230,"amplitude":0.025641,"askPrice":1.2,"askSize":1000,"bidPrice":1.18,"bidSize":48000,"shortable":0,"etf":0,"ttmEps":0.21792905902407508,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732066200000},"adr":0,"listingDate":1607529600000,"adjPreClose":1.17,"openAndCloseTimeList":[[1731979800000,1731988800000],[1731992400000,1732003200000]],"volumeRatio":0.469845,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02142/tweets","defaultTab":"tweets","newsList":[{"id":"2484623925","title":"和铂医药-B回购20万股 回购金额达23.8万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484623925","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484623925?lang=zh_cn&edition=full","pubTime":"2024-11-18 18:51","pubTimestamp":1731927060,"startTime":"0","endTime":"0","summary":"财中社11月18日电和铂医药-B 发布公告，披露了2024年11月18日的股份变动情况。公告显示，公司于11月18日回购了20万股普通股，每股最低回购价格为1.18港元每股最高回购价格为1.19港元，总支付金额为23.8万港元。此次回购后，公司已发行股份总数为7.7亿股，库存股份增加至366万股。此次回购是在公司于2024年6月6日通过的回购授权下进行的，授权总数为7689万股。回购股份的暂止期将持续至2024年12月18日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118185932a242d14e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118185932a242d14e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","BK1574","02142"],"gpt_icon":0},{"id":"2484642584","title":"和铂医药-B(02142)11月18日斥资23.78万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2484642584","media":"智通财经","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484642584?lang=zh_cn&edition=full","pubTime":"2024-11-18 18:27","pubTimestamp":1731925674,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和铂医药-B(02142)发布公告，于2024年11月18日，该公司斥资23.78万港元回购20万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1212376.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1583","BK1574","02142"],"gpt_icon":0},{"id":"2483671003","title":"和铂医药宣布任命郑雷博士为首席商务官","url":"https://stock-news.laohu8.com/highlight/detail?id=2483671003","media":"美通社","labels":["Executive Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483671003?lang=zh_cn&edition=full","pubTime":"2024-11-15 09:55","pubTimestamp":1731635700,"startTime":"0","endTime":"0","summary":"中国苏州、美国马萨诸塞州剑桥和荷兰鹿特丹2024年11月15日 /美通社/ -- 和铂医药，一家专注于肿瘤及免疫领域创新抗体疗法发现、开发及商业化的全球化生物医药公司，今日宣布正式任命郑雷博士为首席商务官。在加入和铂医药之前，郑博士创立并担任Urica Therapeutics的首席科学官，该公司是一家临床阶段公司，当时正在开发一款针对难治性痛风的口服疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4557860_ZH57860_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Executive Changes","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1574","BK1583","02142","CBO","BK1161"],"gpt_icon":0},{"id":"2482026207","title":"和铂医药回购20万股 总支出24万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482026207","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482026207?lang=zh_cn&edition=full","pubTime":"2024-11-11 19:41","pubTimestamp":1731325307,"startTime":"0","endTime":"0","summary":"财中社11月11日电和铂医药-B（02142）发布公告，披露截至2024年11月11日的股份变动情况。公告显示，公司在2024年11月11日回购了20万股普通股，回购价格为每股1.20275港元，总支出为24万港元。回购后，公司的已发行股份（不包括库存股份）总数为7.65亿股，库存股份数目为346万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411113235929685.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK1583","BK1574","02142"],"gpt_icon":0},{"id":"2482207684","title":"和铂医药-B(02142)11月11日斥资24.06万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2482207684","media":"智通财经","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482207684?lang=zh_cn&edition=full","pubTime":"2024-11-11 19:38","pubTimestamp":1731325122,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和铂医药-B(02142)发布公告，该公司于2024年11月11日斥资24.06万港元回购20万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1209434.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02142","BK1574","BK1583","BK1161"],"gpt_icon":0},{"id":"2481106834","title":"和铂医药回购30万股，总支出为35.7万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481106834","media":"财中社","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481106834?lang=zh_cn&edition=full","pubTime":"2024-11-08 21:47","pubTimestamp":1731073620,"startTime":"0","endTime":"0","summary":"财中社11月8日电和铂医药-B（02142）发布公告，截至2024年11月8日，公司已发行股份总数为7.69亿股，其中普通股7.66亿股，库存股326万股。在2024年11月8日，公司回购了30万股，回购均价为每股1.19093港元，总支出为35.7万港元。这一回购行为使得已发行股份（不包括库存股份）减少了0.0392%。公告中提到，自2024年6月6日获得回购授权以来，公司共回购股份326万股，占当日已发行股份（不包括库存股份）总数的0.424%。公司在回购股份后，计划于2024年12月8日之前暂停任何新股发行或库存股份的出售。此次回购符合《主板上市规则》的相关规定。（文章来源：财中社）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108215059abae22d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108215059abae22d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02142","BK1583","BK1574"],"gpt_icon":0},{"id":"2481176092","title":"和铂医药-B(02142)11月8日斥资35.73万港元回购30万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2481176092","media":"智通财经","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481176092?lang=zh_cn&edition=full","pubTime":"2024-11-08 20:10","pubTimestamp":1731067832,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和铂医药-B(02142)发布公告，于2024年11月8日斥资35.73万港元回购股份30万股，每股回购价格为1.17-1.21港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1208787.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02142","BK1161","BK1574","BK1583"],"gpt_icon":0},{"id":"2481106756","title":"和铂医药向国家药品监督管理局递交HBM9378/SKB378治疗慢性阻塞性肺疾病的临床试验申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2481106756","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481106756?lang=zh_cn&edition=full","pubTime":"2024-11-08 17:42","pubTimestamp":1731058920,"startTime":"0","endTime":"0","summary":"其较长的半衰期优化设计和优秀的理化性质使HBM9378/SKB378在给药和剂型方面拥有潜在优势。我们对HBM9378/SKB378的前景充满信心，并相信这一新型疗法能够满足慢性阻塞性肺疾病患者的多样化需求。目前，公司已在中国完成了HBM9378/SKB378针对中重度哮喘治疗的I期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4551688_ZH51688_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1583","02142","BK1574","TSLP","BK1161"],"gpt_icon":0},{"id":"2481125119","title":"和铂医药提交抗COPD新药临床申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2481125119","media":"财中社","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481125119?lang=zh_cn&edition=full","pubTime":"2024-11-08 17:35","pubTimestamp":1731058534,"startTime":"0","endTime":"0","summary":"财中社11月8日电和铂医药-B（02142）发布公告，公司已向国家药品监督管理局提交了抗TSLP全人源单克隆抗体HBM9378（或SKB378）的新药临床试验申请。该药物旨在治疗慢性阻塞性肺疾病（COPD），是与四川科伦博泰生物医药股份有限公司共同开发的项目，双方共同享有该药物的全球权利。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411083234177851.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK1583","BK1574","02142"],"gpt_icon":0},{"id":"2481233271","title":"和铂医药-B(02142.HK)就治疗慢性阻塞性肺疾病药物提交新药临床试验申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2481233271","media":"阿斯达克财经","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481233271?lang=zh_cn&edition=full","pubTime":"2024-11-08 17:24","pubTimestamp":1731057840,"startTime":"0","endTime":"0","summary":"和铂医药-B(02142.HK) 公布，已向国家药品监督管理局提交了一项新药临床试验申请，药物HBM9378/SKB378由公司与科伦博泰-B(06990.HK) 共同开发，用于治疗慢性阻塞性肺疾病，目前公司已在内地完成药物针对中重度哮喘治疗的I期临床试验。(vc/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-11-08 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210504112141597_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210504112141597_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1395338/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["03347","02142","BK1161","BK1574","BK1583","BK1576","BK1141"],"gpt_icon":0},{"id":"2481402231","title":"和铂医药-B(02142)：抗TSLP全人源单克隆抗体(HBM9378/SKB378)慢性阻塞性肺疾病新药临床申请提交国家药品监督管理局","url":"https://stock-news.laohu8.com/highlight/detail?id=2481402231","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481402231?lang=zh_cn&edition=full","pubTime":"2024-11-08 17:10","pubTimestamp":1731057030,"startTime":"0","endTime":"0","summary":"和铂医药-B(02142)发布公告，集团已向国家药品监督管理局提交了一项 \nHBM...","market":"sh","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_17.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_17.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1208555.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02142","BK1574","BK1161","TSLP","BK1583"],"gpt_icon":0},{"id":"2481801971","title":"和铂医药-B(02142)11月7日斥资20.63万港元回购17.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2481801971","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481801971?lang=zh_cn&edition=full","pubTime":"2024-11-07 19:02","pubTimestamp":1730977345,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和铂医药-B(02142)发布公告，该公司于2024年11月7日斥资20.63万港元回购17.4万股股份，每股回购价格为1.17-1.19港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1208132.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02142","BK1583","BK1574","BK1161"],"gpt_icon":0},{"id":"2481673038","title":"和铂医药-B(02142)11月6日斥资32.91万港元回购28.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2481673038","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481673038?lang=zh_cn&edition=full","pubTime":"2024-11-06 18:29","pubTimestamp":1730888962,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和铂医药-B(02142)发布公告，该公司于2024年11月6日斥资32.91万港元回购28.4万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1207547.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1583","BK1574","02142"],"gpt_icon":0},{"id":"2481645525","title":"和铂医药-B(02142)下跌5.0%，报1.14元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2481645525","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481645525?lang=zh_cn&edition=full","pubTime":"2024-11-06 14:08","pubTimestamp":1730873285,"startTime":"0","endTime":"0","summary":"11月6日，和铂医药-B(02142)盘中下跌5.0%，截至14:08，报1.14元/股，成交254.92万元。和铂医药控股有限公司是一家全球化生物制药企业，专注于肿瘤及免疫性疾病领域的创新药研发及商业化。公司的业务包括自主研发、联合开发创新药物，对外技术授权，以及与全球顶尖学术机构及生物医药公司的创新合作。截至2024年中报，和铂医药-B营业总收入1.69亿元、净利润1014.86万元。11月4日，公司以每股1.19-1.2港元回购9万股,回购金额10.78万港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/06140844984784.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02142","BK1161","BK1574","BK1583"],"gpt_icon":0},{"id":"2481064512","title":"和铂医药-B盘中异动 下午盘大幅跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481064512","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481064512?lang=zh_cn&edition=full","pubTime":"2024-11-06 14:08","pubTimestamp":1730873281,"startTime":"0","endTime":"0","summary":"2024年11月06日下午盘14时08分，和铂医药-B股票出现波动，股价大幅下挫5.00%。截至发稿，该股报1.140港元/股，成交量219万股，换手率0.29%，振幅4.17%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。和铂医药-B股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，华康生物医学、盛禾生物-B、荃信生物-B涨幅较大，振幅较大的相关个股有绿竹生物-B、华康生物医学、来凯医药-B，振幅分别为17.45%、15.93%、13.44%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106140801971a4a2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106140801971a4a2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","02142","BK1583"],"gpt_icon":0},{"id":"2480730433","title":"和铂医药-B(02142)11月4日斥资10.78万港元回购9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2480730433","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480730433?lang=zh_cn&edition=full","pubTime":"2024-11-04 20:14","pubTimestamp":1730722468,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和铂医药-B(02142)发布公告，于2024年11月4日，该公司斥资10.78万港元回购9万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1206511.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","02142","BK1161","BK1574"],"gpt_icon":0},{"id":"2480407717","title":"和铂医药回购13.2万股 总支付15.78万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480407717","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480407717?lang=zh_cn&edition=full","pubTime":"2024-11-01 17:42","pubTimestamp":1730454167,"startTime":"0","endTime":"0","summary":"财中社11月1日电和铂医药-B（02142）发布公告，2024年11月1日公司回购13.2万股普通股，回购价格为每股1.19508港元，总支付金额为15.78万港元。此次回购股份的变动使得截至2024年11月1日的已发行股份总数为7.66亿股，库存股份增至241万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411013226715216.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1583","02142","BK1161","BK1574"],"gpt_icon":0},{"id":"2480544074","title":"和铂医药-B(02142)11月1日斥资15.78万港元回购13.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2480544074","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480544074?lang=zh_cn&edition=full","pubTime":"2024-11-01 17:19","pubTimestamp":1730452759,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和铂医药-B(02142)发布公告，该公司于2024年11月1日斥资15.78万港元回购13.2万股股份，每股回购价格为1.18-1.21港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1205658.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02142","BK1161","BK1574","BK1583"],"gpt_icon":0},{"id":"2479703272","title":"和铂医药-B(02142)10月31日耗资约12.06万港元回购10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2479703272","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479703272?lang=zh_cn&edition=full","pubTime":"2024-10-31 18:23","pubTimestamp":1730370212,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和铂医药-B(02142)公布，2024年10月31日耗资约12.06万港元回购10万股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1205014.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02142","BK1583","BK1161","BK1574"],"gpt_icon":0},{"id":"2479276563","title":"和铂医药-B(02142)10月30日斥资24.36万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2479276563","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479276563?lang=zh_cn&edition=full","pubTime":"2024-10-30 17:59","pubTimestamp":1730282384,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和铂医药-B(02142)发布公告，该公司于2024年10月30日斥资24.36万港元回购20万股股份，每股回购价格为1.19-1.23港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1203766.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1583","BK1574","02142"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0168},{"period":"1month","weight":-0.0714},{"period":"3month","weight":-0.041},{"period":"6month","weight":-0.1643},{"period":"1year","weight":-0.2688},{"period":"ytd","weight":-0.3969}],"compareEarnings":[{"period":"1week","weight":-0.0416},{"period":"1month","weight":-0.059},{"period":"3month","weight":0.118},{"period":"6month","weight":0.0198},{"period":"1year","weight":0.1216},{"period":"ytd","weight":0.1484}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"和铂医药控股有限公司是一家主要从事肿瘤免疫学及免疫性疾病领域的创新疗法开发业务的投资控股公司。该公司的产品包括巴托利单抗，主要用于免疫性血小板减少症、甲状腺相关性眼病、重症肌无力、视神经脊髓炎谱系疾病等;以及特那西普，主要用于干眼病。此外，该公司还研究和开发肿瘤免疫产品管线，包括内部开发的新一代肿瘤免疫资产，针对治疗免疫沙漠型、免疫排斥型及炎症型肿瘤。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.111525},{"month":2,"riseRate":0,"avgChangeRate":-0.110405},{"month":3,"riseRate":0.25,"avgChangeRate":-0.124902},{"month":4,"riseRate":0.5,"avgChangeRate":0.027757},{"month":5,"riseRate":0.5,"avgChangeRate":0.040975},{"month":6,"riseRate":0.25,"avgChangeRate":-0.069984},{"month":7,"riseRate":0.25,"avgChangeRate":0.010824},{"month":8,"riseRate":0,"avgChangeRate":-0.134459},{"month":9,"riseRate":0.25,"avgChangeRate":-0.098643},{"month":10,"riseRate":0,"avgChangeRate":-0.190485},{"month":11,"riseRate":0.75,"avgChangeRate":0.322177},{"month":12,"riseRate":0.666667,"avgChangeRate":0.280942}],"exchange":"SEHK","name":"和铂医药-B","nameEN":"HBM HOLDINGS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和铂医药-B(02142)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和铂医药-B(02142)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和铂医药-B,02142,和铂医药-B股票,和铂医药-B股票老虎,和铂医药-B股票老虎国际,和铂医药-B行情,和铂医药-B股票行情,和铂医药-B股价,和铂医药-B股市,和铂医药-B股票价格,和铂医药-B股票交易,和铂医药-B股票购买,和铂医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和铂医药-B(02142)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和铂医药-B(02142)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}